市場調査レポート
商品コード
1604096

そう痒症治療薬の世界市場 (2024~2028年)

Global Pruritus Drugs Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 157 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
そう痒症治療薬の世界市場 (2024~2028年)
出版日: 2024年10月18日
発行: TechNavio
ページ情報: 英文 157 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

そう痒症治療薬市場 (2024~2028年)

そう痒症治療薬市場は2023-2028年に59億米ドル分拡大し、予測期間中に7.1%のCAGRで成長すると予測されます。当レポートでは、そう痒症治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、免疫療法の人気拡大、慢性疾患の有病率の上昇、治療薬の認知度向上と利用増加によって牽引されています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024~2028年
成長モメンタム 加速
前年比 (2024年) 6.3%
CAGR 7.1%
増分額 59億米ドル

当レポートでは、今後数年間のそう痒症治療薬市場の成長を促進する主な要因の1つとして、新規治療オプションの出現を挙げています。また、ナノ粒子を利用した経皮ドラッグデリバリーシステムや、研究資金の増加が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 (2023年)
  • 市場の見通し (2023~2028年)

第4章 市場規模実績

  • そう痒症治療薬の世界市場 (2018~2022年)
  • 用途別分析 (2018~2022年)
  • 地域別分析 (2018~2022年)
  • 国別分析 (2018~2022年)

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:用途別

  • 市場セグメント
  • 比較:用途別
  • 血液性そう痒症:市場規模と予測 (2023~2028年)
  • 腫瘍性そう痒症:市場規模と予測 (2023~2028年)
  • 腎臓そう痒症:市場規模と予測 (2023~2028年)
  • 内分泌そう痒症:市場規模と予測 (2023~2028年)
  • 胆汁うっ滞性そう痒症:市場規模と予測 (2023~2028年)
  • 市場機会:用途別

第7章 顧客情勢

  • 顧客情勢の概要

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 (2023~2028年)
  • 欧州:市場規模と予測 (2023~2028年)
  • アジア:市場規模と予測 (2023~2028年)
  • 世界のその他の地域:市場規模と予測 (2023~2028年)
  • 米国:市場規模と予測 (2023~2028年)
  • 英国:市場規模と予測 (2023~2028年)
  • ドイツ:市場規模と予測 (2023~2028年)
  • 中国:市場規模と予測 (2023~2028年)
  • フランス:市場規模と予測 (2023~2028年)
  • 市場機会:地域別

第9章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第10章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第11章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Cara Therapeutics Inc.
  • GlaxoSmithKline Plc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roivant Sciences Ltd.
  • Sanofi SA

第12章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Parent Market
  • Exhibits10: Data Table on - Parent Market
  • Exhibits11: Market characteristics analysis
  • Exhibits12: Value Chain Analysis
  • Exhibits13: Offerings of companies included in the market definition
  • Exhibits14: Market segments
  • Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Historic Market Size - Data Table on Global Pruritus Drugs Market 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Application - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Oncological pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Oncological pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Renal pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Renal pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Chart on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits47: Data Table on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits48: Chart on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Data Table on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits50: Chart on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits51: Data Table on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
  • Exhibits52: Chart on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Market opportunity by Application ($ billion)
  • Exhibits55: Data Table on Market opportunity by Application ($ billion)
  • Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits57: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits59: Chart on Geographic comparison
  • Exhibits60: Data Table on Geographic comparison
  • Exhibits61: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits63: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits78: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits79: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits94: Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Exhibits95: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits98: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits99: Impact of drivers and challenges in 2023 and 2028
  • Exhibits100: Overview on criticality of inputs and factors of differentiation
  • Exhibits101: Overview on factors of disruption
  • Exhibits102: Impact of key risks on business
  • Exhibits103: Companies covered
  • Exhibits104: Matrix on companies position and classification
  • Exhibits105: AbbVie Inc. - Overview
  • Exhibits106: AbbVie Inc. - Product / Service
  • Exhibits107: AbbVie Inc. - Key news
  • Exhibits108: AbbVie Inc. - Key offerings
  • Exhibits109: Astellas Pharma Inc. - Overview
  • Exhibits110: Astellas Pharma Inc. - Product / Service
  • Exhibits111: Astellas Pharma Inc. - Key offerings
  • Exhibits112: Cara Therapeutics Inc. - Overview
  • Exhibits113: Cara Therapeutics Inc. - Product / Service
  • Exhibits114: Cara Therapeutics Inc. - Key offerings
  • Exhibits115: GlaxoSmithKline Plc - Overview
  • Exhibits116: GlaxoSmithKline Plc - Business segments
  • Exhibits117: GlaxoSmithKline Plc - Key news
  • Exhibits118: GlaxoSmithKline Plc - Key offerings
  • Exhibits119: GlaxoSmithKline Plc - Segment focus
  • Exhibits120: Lupin Ltd. - Overview
  • Exhibits121: Lupin Ltd. - Business segments
  • Exhibits122: Lupin Ltd. - Key news
  • Exhibits123: Lupin Ltd. - Key offerings
  • Exhibits124: Lupin Ltd. - Segment focus
  • Exhibits125: Merck and Co. Inc. - Overview
  • Exhibits126: Merck and Co. Inc. - Business segments
  • Exhibits127: Merck and Co. Inc. - Key news
  • Exhibits128: Merck and Co. Inc. - Key offerings
  • Exhibits129: Merck and Co. Inc. - Segment focus
  • Exhibits130: Novartis AG - Overview
  • Exhibits131: Novartis AG - Business segments
  • Exhibits132: Novartis AG - Key news
  • Exhibits133: Novartis AG - Key offerings
  • Exhibits134: Novartis AG - Segment focus
  • Exhibits135: Pfizer Inc. - Overview
  • Exhibits136: Pfizer Inc. - Product / Service
  • Exhibits137: Pfizer Inc. - Key news
  • Exhibits138: Pfizer Inc. - Key offerings
  • Exhibits139: Roivant Sciences Ltd. - Overview
  • Exhibits140: Roivant Sciences Ltd. - Product / Service
  • Exhibits141: Roivant Sciences Ltd. - Key offerings
  • Exhibits142: Sanofi SA - Overview
  • Exhibits143: Sanofi SA - Business segments
  • Exhibits144: Sanofi SA - Key news
  • Exhibits145: Sanofi SA - Key offerings
  • Exhibits146: Sanofi SA - Segment focus
  • Exhibits147: Inclusions checklist
  • Exhibits148: Exclusions checklist
  • Exhibits149: Currency conversion rates for US$
  • Exhibits150: Research methodology
  • Exhibits151: Information sources
  • Exhibits152: Data validation
  • Exhibits153: Validation techniques employed for market sizing
  • Exhibits154: Data synthesis
  • Exhibits155: 360 degree market analysis
  • Exhibits156: List of abbreviations
目次
Product Code: IRTNTR72374

Pruritus Drugs Market 2024-2028

The pruritus drugs market is forecasted to grow by USD 5.9 bn during 2023-2028, accelerating at a CAGR of 7.1% during the forecast period. The report on the pruritus drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing preference for immunotherapy, rising prevalence of chronic diseases, and increasing awareness and rising use of therapeutics.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.3%
CAGR7.1%
Incremental Value$5.9 bn

Technavio's pruritus drugs market is segmented as below:

By Application

    • Hematologic pruritus
    • Oncological pruritus
    • Renal pruritus
    • Endocrine pruritus
    • Cholestatic pruritus

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the emergence of novel treatment options as one of the prime reasons driving the pruritus drugs market growth during the next few years. Also, nanoparticle-enabled transdermal drug delivery systems and increasing research funding will lead to sizable demand in the market.

The report on the pruritus drugs market covers the following areas:

    • Pruritus Drugs Market sizing
    • Pruritus Drugs Market forecast
    • Pruritus Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus drugs market vendors that include AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol Myers Squibb Co., Cara Therapeutics Inc., Cipla Inc., Eisai Co. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Ipca Laboratories, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, and Sun Pharmaceutical Industries Ltd.. Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Pruritus Drugs Market 2018 - 2022
    • Historic Market Size - Data Table on Global Pruritus Drugs Market 2018 - 2022 ($ billion)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ billion)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Hematologic pruritus - Market size and forecast 2023-2028
    • Chart on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Hematologic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Hematologic pruritus - Year-over-year growth 2023-2028 (%)
  • 6.4 Oncological pruritus - Market size and forecast 2023-2028
    • Chart on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oncological pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oncological pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Oncological pruritus - Year-over-year growth 2023-2028 (%)
  • 6.5 Renal pruritus - Market size and forecast 2023-2028
    • Chart on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Renal pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Renal pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Renal pruritus - Year-over-year growth 2023-2028 (%)
  • 6.6 Endocrine pruritus - Market size and forecast 2023-2028
    • Chart on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Endocrine pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Endocrine pruritus - Year-over-year growth 2023-2028 (%)
  • 6.7 Cholestatic pruritus - Market size and forecast 2023-2028
    • Chart on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Cholestatic pruritus - Market size and forecast 2023-2028 ($ billion)
    • Chart on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
    • Data Table on Cholestatic pruritus - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Application
    • Market opportunity by Application ($ billion)
    • Data Table on Market opportunity by Application ($ billion)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 8.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 8.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 8.11 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ billion)
    • Data Table on France - Market size and forecast 2023-2028 ($ billion)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
  • 11.4 Astellas Pharma Inc.
    • Astellas Pharma Inc. - Overview
    • Astellas Pharma Inc. - Product / Service
    • Astellas Pharma Inc. - Key offerings
  • 11.5 Cara Therapeutics Inc.
    • Cara Therapeutics Inc. - Overview
    • Cara Therapeutics Inc. - Product / Service
    • Cara Therapeutics Inc. - Key offerings
  • 11.6 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
  • 11.7 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
  • 11.8 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 11.9 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 11.10 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 11.11 Roivant Sciences Ltd.
    • Roivant Sciences Ltd. - Overview
    • Roivant Sciences Ltd. - Product / Service
    • Roivant Sciences Ltd. - Key offerings
  • 11.12 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
  • 12.9 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations